Bluejay Diagnostics, Inc.

BJDX Nasdaq CIK: 0001704287

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 360 MASSACHUSETTS AVENUE, SUITE 203, ACTON, MA, 01720
Mailing Address 360 MASSACHUSETTS AVENUE, SUITE 203, ACTON, MA, 01720
Phone (978) 631-0152
Fiscal Year End 1231
EIN 473552922

Financial Overview

FY2024

$1.97M
Total Liabilities
$4.30M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 5, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 5, 2026 View on SEC
8-K Current report of material events January 30, 2026 View on SEC
8-K Current report of material events December 30, 2025 View on SEC
8-K Current report of material events November 10, 2025 View on SEC
10-Q Quarterly financial report November 7, 2025 View on SEC
S-3 Shelf registration for future offerings October 23, 2025 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) October 16, 2025 View on SEC
8-K Current report of material events October 14, 2025 View on SEC

Material Events

8-K Financial Distress January 30, 2026
High Impact
  • Aims to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share.
  • Maintains public listing on the Nasdaq Capital Market, supporting credibility and access to capital markets.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.